OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
August 14, 2013
Rapid screening of critical API properties can quickly identify the best approach for increasing bioavailability.
August 07, 2013
The companies initially focused on five biosimilar products.
Adamis Pharmaceuticals agrees to license and potentially acquire 3M's Taper Dry Powder Inhaler technology.
Pfizer, Merck, Sanofi, and AstraZeneca are among the companies reporting revenue declines from generic-drug incursion. A look at what the companies are doing to stimulate growth.
August 06, 2013
A new study reveals how a promising anticancer specifically kills prostate cancer cells by compromising their ability to withstand environmental stress.
August 02, 2013
Extensive comparability testing is required to ensure that biosimilars have comparable profiles to their reference products.
The US Supreme Court's Myriad decision satisfied both patient groups and patent holders
Advances in techniques and single-use systems are revolutionizing vaccine manufacturing.
FDA releases FY 2014 generic-drug user fees.
FDA funds research to further development of innovative generics, while working to address review and approval issues.